Options: Show MedDRA Preferred Terms
Side effect | Data for drug | Placebo | Labels |
---|---|---|---|
1 | |||
Pruritus | 16.1% - 27.6% | x | |
Unspecified disorder of skin and subcutaneous tissue | 16.1% - 27.6% | x | |
Hypotension | 2.19% - 6.71% | x | |
Angiopathy | 2.19% - 6.71% | x | |
Mediastinal disorder | 0.813% - 10.7% | x | |
Hypoxemia | 0.813% - 10.7% | x | |
Apnoea | x | ||
Cough | x | ||
Gastrointestinal disorder | x | ||
Headache | x | ||
Nausea | x | ||
Nervous system disorder | x | ||
Paraesthesia | x | ||
Vomiting | x | ||
Respiratory depression | x | ||
Stinging | x | ||
Non-sustained ventricular tachycardia | x | ||
Hepatic insufficiency | x | ||
Procedural pain | 0% - 2.01% | x | |
Tingling sensation | x |
Information about indications was extracted from the indications and usage sections of the labels.
Indication | Labels | ||
---|---|---|---|
Acute myeloid leukaemia | x |
standard – alternative
100% | ||
75% | ||
50% | ||
10% | ||
frequent (1% to 100%) | ||
infrequent (0.1% to 1%) | ||
rare (<0.1%) | ||
postmarketing | ||
0% | ||
no frequency information | ||
not found on label |